Brief: Theratechnologies TH1902 Study Published In Pharmaceutics Shows Inhibition Of Human Sortilin (Sort1)-Positive Ovarian And Triple-Negative Breast Cancer Stem-Like Cells And Tumor Growth

Theratechnologies

12/09/2022 13:21

Sept 12 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES TH1902 STUDY PUBLISHED IN PHARMACEUTICS
DEMONSTRATES INHIBITION OF HUMAN SORTILIN (SORT1)-POSITIVE
OVARIAN AND TRIPLE-NEGATIVE BREAST CANCER STEM-LIKE CELLS AND
TUMOR GROWTH

Source text for Eikon:  ID:nGNXbG7NRw 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))